Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $27,200 | 29 | 50.4% |
| Food and Beverage | $11,064 | 574 | 20.5% |
| Consulting Fee | $8,750 | 3 | 16.2% |
| Travel and Lodging | $6,466 | 21 | 12.0% |
| Education | $440.44 | 14 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $35,189 | 186 | $0 (2024) |
| Minerva Surgical, Inc | $11,038 | 20 | $0 (2024) |
| Astellas Pharma US Inc | $1,214 | 57 | $0 (2024) |
| Allergan, Inc. | $754.05 | 72 | $0 (2022) |
| Corcept Therapeutics | $598.11 | 23 | $0 (2021) |
| Novo Nordisk Inc | $546.72 | 33 | $0 (2024) |
| Aspira Women's Health Inc | $355.11 | 5 | $0 (2023) |
| TherapeuticsMD, Inc. | $340.96 | 16 | $0 (2022) |
| PFIZER INC. | $310.96 | 20 | $0 (2024) |
| Vertical Pharmaceuticals, LLC | $264.10 | 15 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,037 | 51 | Astellas Pharma US Inc ($341.30) |
| 2023 | $1,287 | 80 | AbbVie Inc. ($326.36) |
| 2022 | $2,371 | 69 | ABBVIE INC. ($1,349) |
| 2021 | $14,815 | 118 | AbbVie Inc. ($13,646) |
| 2020 | $2,223 | 72 | AbbVie Inc. ($1,413) |
| 2019 | $14,747 | 99 | AbbVie, Inc. ($13,883) |
| 2018 | $10,263 | 88 | Minerva Surgical, Inc ($4,723) |
| 2017 | $7,177 | 64 | MINERVA SURGICAL, INC ($6,107) |
All Payment Transactions
641 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Biological | ||||||
| 12/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: PAIN | ||||||
| 12/02/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Obesity | ||||||
| 11/25/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Bone Health | ||||||
| 11/20/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $13.79 | General |
| 11/18/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: Biological | ||||||
| 11/04/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $10.05 | General |
| Category: Biological | ||||||
| 10/28/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: Obesity | ||||||
| 10/28/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $9.78 | General |
| Category: Biological | ||||||
| 10/23/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 09/30/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Biological | ||||||
| 09/13/2024 | Minerva Surgical, Inc | — | Food and Beverage | In-kind items and services | $61.03 | General |
| Category: Ablation System | ||||||
| 09/10/2024 | PFIZER INC. | PREMARIN (Drug), DUAVEE, MYFEMBREE | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: WOMENS HEALTH | ||||||
| 09/10/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart, Flector | Food and Beverage | Cash or cash equivalent | $16.27 | General |
| Category: Endocrinology | ||||||
| 09/05/2024 | Hologic Sales and Service, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Diagnostics | ||||||
| 08/26/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Biological | ||||||
| 08/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Obesity | ||||||
| 08/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: PAIN | ||||||
| 07/29/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Bone Health | ||||||
| 07/09/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Diabetes | ||||||
| 07/03/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 07/01/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Oncology | ||||||
| 06/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Obesity | ||||||
| 06/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 184 | 217 | $24,493 | $10,926 |
| 2022 | 7 | 219 | 248 | $25,924 | $12,317 |
| 2021 | 5 | 255 | 284 | $28,605 | $13,473 |
| 2020 | 7 | 365 | 449 | $44,673 | $17,768 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 39 | 61 | $11,590 | $4,530 | 39.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 48 | $6,048 | $2,901 | 48.0% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 38 | 38 | $2,850 | $1,410 | 49.5% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 26 | 26 | $1,170 | $1,047 | 89.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 19 | 19 | $1,710 | $596.26 | 34.9% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2023 | 25 | 25 | $1,125 | $442.25 | 39.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 31 | 52 | $9,880 | $3,983 | 40.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 36 | 40 | $5,040 | $2,484 | 49.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 47 | 47 | $3,525 | $1,814 | 51.5% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 40 | 40 | $1,800 | $1,663 | 92.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $2,304 | $968.44 | 42.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 14 | 18 | $1,620 | $708.97 | 43.8% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2022 | 39 | 39 | $1,755 | $694.59 | 39.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 36 | 54 | $10,260 | $4,420 | 43.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 64 | 75 | $9,450 | $3,947 | 41.8% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 64 | 64 | $4,800 | $2,474 | 51.5% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 41 | 41 | $1,845 | $1,729 | 93.7% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2021 | 50 | 50 | $2,250 | $902.50 | 40.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 86 | 148 | $18,648 | $6,018 | 32.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 38 | 57 | $10,830 | $3,669 | 33.9% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 79 | 79 | $5,925 | $3,080 | 52.0% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 60 | 60 | $2,700 | $2,470 | 91.5% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2020 | 72 | 72 | $3,240 | $1,296 | 40.0% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 15 | 15 | $2,880 | $1,176 | 40.8% |
| 81002 | Urinalysis, manual test | Office | 2020 | 15 | 18 | $450.00 | $58.67 | 13.0% |
About Dr. Laurianne Scott, DO
Dr. Laurianne Scott, DO is a Obstetrics & Gynecology healthcare provider based in Lancaster, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538132139.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Laurianne Scott, DO has received a total of $53,920 in payments from pharmaceutical and medical device companies, with $1,037 received in 2024. These payments were reported across 641 transactions from 49 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($27,200).
As a Medicare-enrolled provider, Scott has provided services to 1,023 Medicare beneficiaries, totaling 1,198 services with total Medicare billing of $54,483. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Other Specialties Obstetrics & Gynecology
- Location Lancaster, OH
- Active Since 02/13/2006
- Last Updated 03/04/2009
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1538132139
Products in Payments
- Orilissa (Drug) $16,529
- ORIAHNN (Drug) $10,272
- ENDOMETRIAL ABLATION SYSTEM (Device) $6,107
- ORILISSA (Drug) $5,854
- Endometrial Ablation System (Device) (Device) $4,723
- Lupron (Drug) $1,854
- Korlym (Drug) $598.11
- UBRELVY (Drug) $421.30
- Myrbetriq (Drug) $369.75
- OVA1 (Device) $355.11
- MYRBETRIQ (Drug) $315.93
- Wegovy (Drug) $314.72
- LO LOESTRIN FE (Drug) $304.43
- ZENPEP (Drug) $260.23
- CONTRAVE (Drug) $254.15
- Osphena (Drug) $253.69
- EVENITY (Biological) $250.88
- DIVIGEL (Drug) $249.24
- INTRAROSA (Drug) $248.08
- MYFEMBREE (Drug) $221.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Lancaster
Sarah Eiser, M.d, M.D
Obstetrics & Gynecology — Payments: $53,863
Dr. Kerry-Anne Perkins, Do, DO
Obstetrics & Gynecology — Payments: $25,951
John Navas
Obstetrics & Gynecology — Payments: $8,061
Dr. Christine Skiadas, M.d, M.D
Obstetrics & Gynecology — Payments: $5,237
Sean Jerig, M.d, M.D
Obstetrics & Gynecology — Payments: $4,966
Sarah Froman, Md, MD
Obstetrics & Gynecology — Payments: $4,634